Research on pharmaceutical management provisions in the <italic style="font-style: italic">Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province </italic>（<italic style="font-style: italic">2024 Edition</italic>）

ZHAO Linlin; LU Yuanyuan; LIU Maochang; JIN Fan; PANG Liangfang; FU Wei

doi:10.6039/j.issn.1001-0408.2024.23.04

您当前的位置：

首页 >

文章列表页 >

Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）

更新时间：2024-12-09

- Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）
- ZHONGGUO YAOFANG Vol. 35, Issue 23, Pages: 2858-2862(2024)
- 作者机构：
  
  1.中部战区总医院临床药学科，武汉　430070
  2.湖北省妇幼保健院药学部，武汉　430064
  3.武汉儿童医院药学部，武汉　430019
  4.宜昌妇幼保健院药学部，湖北宜昌　443000
  5.华中科技大学同济医学院附属同济医院药学部，武汉　430030
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.23.04
  CLC： R951
- Published：15 December 2024，
  
  Received：30 May 2024，
  
  Revised：10 November 2024，
- 稿件说明：
移动端阅览
赵琳琳,卢圆圆,刘茂昌等.《湖北省三级妇幼保健院评审标准（2024年版）》药事管理条款研究 ^Δ[J].中国药房,2024,35(23):2858-2862.

ZHAO Linlin,LU Yuanyuan,LIU Maochang,et al.Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）[J].ZHONGGUO YAOFANG,2024,35(23):2858-2862.
赵琳琳,卢圆圆,刘茂昌等.《湖北省三级妇幼保健院评审标准（2024年版）》药事管理条款研究 ^Δ[J].中国药房,2024,35(23):2858-2862. DOI： 10.6039/j.issn.1001-0408.2024.23.04.

ZHAO Linlin,LU Yuanyuan,LIU Maochang,et al.Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）[J].ZHONGGUO YAOFANG,2024,35(23):2858-2862. DOI： 10.6039/j.issn.1001-0408.2024.23.04.

摘要

目的

对《湖北省三级妇幼保健院评审标准（2024年版）》（简称《2024版湖北妇幼标准》）中的药事管理条款进行研究。

方法

阐述《2024版湖北妇幼标准》中药事管理条款和管理细则的制定过程，同时比较其药事管理条款与《三级妇幼保健院评审标准（2016年版）》中药事管理条款的异同，分析其药事管理特有条款的制定依据，并在此基础上提出进一步改进的建议。结果与

结论

与《三级妇幼保健院评审标准（2016年版）》比较，《2024版湖北妇幼标准》中涉及药事管理的相同点主要体现在：应遵守的相关法律、法规、规章制度及人员要求，药品采购、储备、贮存及召回全流程管理，药品调剂与制剂管理等方面；《2024版湖北妇幼标准》特有条款主要体现在：成立儿童用药工作组，建立儿童专用药品目录，制定结余药品管理制度和超说明书用药管理等方面。药事管理特有条款的制定既符合近年来国家新发布的政策要求，又结合了妇幼保健院的特点和实际情况。但《2024版湖北妇幼标准》应在加强细节管理、强化中药合理应用管理方面进一步完善。

Abstract

OBJECTIVE

To study pharmaceutical management provisions in the

Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province

（

2024 Edition

）（hereinafter referred to as

2024 Edition of Hubei Maternal and Child Health Care Standards

）.

METHODS

The formulation of pharmaceutical management clauses and management rules in the

2024 Edition of Hubei Maternal and Child Health Care Standards

was elaborated and compared with the pharmaceutical management clauses in the

Evaluation Standards for Third-level Maternal and Child Health Care Hospitals

（

2016 Edition

） to find out their similarities and differences； the basis for the formulation of unique pharmaceutical management clauses was analyzed， so as to propose further improvement suggestions.

RESULTS &CONCLUSIONS

Compared with the

Evaluation Standards for Third-level Maternal and Child Health Care Hospitals （2016 Edition）

， the similarities in pharmaceutical management in the

2024 Edition of Hubei Maternal and Child Health Care Standards

were mainly reflected in the relevant laws， regulations， rules and personnel requirements that should be followed， the full process management of drug procurement， reserve， storage and recall， drug dispensing and formulation management， etc. The unique provisions of the

2024 Edition of Hubei Maternal and Child Care Standards

were mainly reflected in the establishment of children’s medication working group， the establishment of a list of children’s specific drugs， the development of surplus drug management system， and the management of off-label drug use， etc. The formulation of unique provisions for pharmaceutical management not only conformed to the newly released policy requirements in recent years， but also combined the characteristics and actual situation of maternal and child health care hospitals.

2024 Edition of Hubei Maternal and Child Health Care Standards

should be further improved in terms of strengthening detail management and enhancing the rational application management of traditional Chinese medicine.

关键词

妇幼保健院医院评审标准药事管理特殊人群

Keywords

hospital evaluation standardspharmaceutical managementspecial group

references

张艳丽，王吉善，邵明邦，等.《三级医院评审标准》新旧版本比较分析及建议[J]. 中国卫生质量管理，2021，28（5）：19-22.

ZHANG Y L，WANG J S，SHAO M B，et al. Comparison and suggestions of Accreditation Standards for Tertiary General Hospitals 2020 edition and 2011 edition[J]. Chin Health Qual Manag，2021，28（5）：19-22.

国家卫生健康委员会.国家卫生健康委关于印发《三级医院评审标准（2022年版）》及其实施细则的通知[EB/OL].（2022-12-15）[2024-05-30]. https：//www.gov.cn/zhengce/zhengceku/2022-12/18/content_5732583.htmhttps://www.gov.cn/zhengce/zhengceku/2022-12/18/content_5732583.htm.

National Health Commission.Notice of the National Health Commission on issuing The Evaluation Standards for Third-level Hospitals （2022 Edition） and its implementation rules[EB/OL].（2022-12-15）[2024-05-30]. https：//www.gov.cn/zhengce/zhengceku/2022-12/18/content_5732583.htmhttps://www.gov.cn/zhengce/zhengceku/2022-12/18/content_5732583.htm.

湖北省卫生健康委员会.关于印发《湖北省妇幼保健机构评审实施办法》的通知[EB/OL].（2024-03-06）[2024-05-30].https：//wjw.hubei.gov.cn/zfxxgk/zc/gkwj/ywh/202403/t20240307_5111387.shtmlhttps://wjw.hubei.gov.cn/zfxxgk/zc/gkwj/ywh/202403/t20240307_5111387.shtml.

Hubei Provincial Health Commission. Notice on issuing The Implementation Measures for the Evaluation of Maternal and Child Health Care Institutions in Hubei Province[EB/OL].（2024-03-06）[2024-05-30].https：//wjw.hubei.gov.cn/zfxxgk/zc/gkwj/ywh/202403/t20240307_5111387.shtmlhttps://wjw.hubei.gov.cn/zfxxgk/zc/gkwj/ywh/202403/t20240307_5111387.shtml.

国家卫生计生委办公厅.国家卫生计生委办公厅关于印发三级和二级妇幼保健院评审标准实施细则（2016年版）的通知[EB/OL].（2016-09-07）[2024-05-30].http：//www.nhc.gov.cn/fys/s3581/201609/0846109576ae4ebe9b-176ccd57e9cd1e.shtmlhttp://www.nhc.gov.cn/fys/s3581/201609/0846109576ae4ebe9b-176ccd57e9cd1e.shtml.

Office of the National Health and Family Planning Commission.Notice of the Office of the National Health and Family Planning Commission on issuing the implementation rules for the evaluation standards of third- and se- cond-level maternal and child health care hospitals （2016 edition）[EB/OL].（2016-09-07）[2024-05-30].http：//www.nhc.gov.cn/fys/s3581/201609/0846109576ae4ebe9b176-ccd57e9cd1e.shtmlhttp://www.nhc.gov.cn/fys/s3581/201609/0846109576ae4ebe9b176-ccd57e9cd1e.shtml.

国家卫生健康委办公厅.国家卫生健康委办公厅关于进一步加强儿童临床用药管理工作的通知[EB/OL].（2023-01-16）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s7659/202301/2c86ccde273945e48416c1acb2f68687.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/202301/2c86ccde273945e48416c1acb2f68687.shtml.

Office of the National Health Commission.Notice from the Office of the National Health Commission on further strengthening the management of clinical medication for children[EB/OL].（2023-01-16）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s7659/202301/2c86ccde273945e48416-c1acb2f68687.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/202301/2c86ccde273945e48416-c1acb2f68687.shtml.

湖北省卫生健康委员会，湖北省财政厅，湖北省医疗保障局.关于印发《湖北省医疗机构结余药品管理暂行办法》的通知[EB/OL].（2023-03-08）[2024-05-30].https：//www.yxj.org.cn/detailPage?articleId=369818https://www.yxj.org.cn/detailPage?articleId=369818.

Hubei Provincial Health Commission，Hubei Provincial Finance Department，Hubei Provincial Medical Security Bureau. Notice on issuing The Interim Measures for the Management of Surplus Drugs in Medical Institutions in Hubei Province[EB/OL].（2023-03-08）[2024-05-30].https：//www.yxj.org.cn/detailPage?articleId=369818https://www.yxj.org.cn/detailPage?articleId=369818.

国家卫生健康委，国家中医药局.关于开展全面提升医疗质量行动（2023－2025年）的通知[EB/OL].（2023-05-26）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s3585/202305/cfe6b26bce624b9f894cef021a363f3e.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/202305/cfe6b26bce624b9f894cef021a363f3e.shtml.

National Health Commission，State Administration of Traditional Chinese Medicine.Notice on carrying out the comprehensive improvement of medical quality action （2023-2025）[EB/OL].（2023-05-26）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s3585/202305/cfe6b26bce624b9f894ce-f021a363f3e.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/202305/cfe6b26bce624b9f894ce-f021a363f3e.shtml.

国家卫生健康委医政司.关于持续做好抗菌药物临床应用管理有关工作的通知[EB/OL]．（2018-05-09）[2024-05-30]. http：//www.nhc.gov.cn/yzygj/s7659/201805/c79c-998bdf8f4744858051cdfd1e6818.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/201805/c79c-998bdf8f4744858051cdfd1e6818.shtml.

Medical Administration Department of the National Health Commission. Notice on continuously doing a good job in the management of clinical application of antibiotics[EB/OL]．（2018-05-09）[2024-05-30]. http：//www.nhc.gov.cn/yzygj/s7659/201805/c79c998bdf8f4744858051cdf-d1e6818.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/201805/c79c998bdf8f4744858051cdf-d1e6818.shtml.

国家卫生计生委，国家发展改革委，教育部，等.关于印发遏制细菌耐药国家行动计划（2016－2020年）的通知[EB/OL].（2016-08-05）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec8-4d7.shtmlhttp://www.nhc.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec8-4d7.shtml.

National Health and Family Planning Commission，National Development and Reform Commission，Ministry of Education，et al.Notice on issuing the national action plan for containing bacterial drug resistance （2016-2020）[EB/OL].（2016-08-05）[2024-05-30].http：//www.nhc.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec84d-7.shtmlhttp://www.nhc.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec84d-7.shtml.

张文双，张交生，郑跃杰，等.中国儿童合理使用抗菌药物行动计划：2017－2020[J].中国实用儿科杂志，2018，33（1）：1-5.

ZHANG W S，ZHANG J S，ZHENG Y J，et al. Action plan for rational use of antimicrobials for Chinese children：2017-2020[J]. Chin J Pract Pediatr，2018，33（1）：1-5.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmaceutical care for a patient with atrial flutter， atrial fibrillation， placenta praevia hemorrhage and thrombocytopenia-threatened abortion after operation of congenital heart disease

Research advance of population pharmacokinetics of imipenem-cilastatin in special status populations

Use of Severe ADR-inducing Drugs in Special Population in Our Hospital Guided by the Detailed Quantitative Scoring Rules of Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions

Related Author

WANG Qing

QUAN Shuyan

ZUO Jianli

HE Yao

LI Fushu

CHEN Xing

ZHENG Xiaoyuan

LI Xiao

Related Institution

Dept. of Pharmacy， the Second Affiliated Hospital of Army Medical University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）

DOI：10.6039/j.issn.1001-0408.2024.23.04

摘要

Abstract

关键词

Keywords

references